Abstract
Therapy of Philadelphia positive chronic myelogenous leukaemia (CML Ph1) with alpha interferon (IFN-α) resulted in a high frequency of haematological remissions. Effective suppression of the malignant Ph1 clone and concomitant partial or complete restoration of normal haemopoiesis is reproducibly noted in a proportion (30%-50%) of the patients. This and the low incidence of blast crisis underscore the profound effect this therapy has on the disease. Marked heterogeneity in the response to IFN-α was noted as well, and sensitivity or resistance to interferon was phenotypically indistinguishable. Studies of the IFN-resistant disease failed to disclose alteration in IFN receptors or in IFN-inducible genes and are suggestive, therefore, of a limited alteration in IFN-induced intracellular pathways.
Original language | English (US) |
---|---|
Pages (from-to) | 793-798 |
Number of pages | 6 |
Journal | Cancer Surveys |
Volume | 8 |
Issue number | 4 |
State | Published - 1989 |
Keywords
- CML Ph
- cytogenetic responses
- gross inhibition
- interferons
- normal haemopoiesis
- residual disease
- tumour progression
ASJC Scopus subject areas
- Oncology
- Cancer Research